Advertisement

Topics

Merz Pharmaceuticals GmbH and DiaGenic ASA Company Profile

18:00 EDT 23rd September 2017 | BioPortfolio

Merz Pharmaceuticals researches, develops, produces and distributes innovative pharmaceutical products in the areas of neurology and psychiatry as well as in aesthetic dermatology and metabolism. In the area of Alzheimer's research, Merz Pharmaceuticals has achieved a leading position with the first active ingredient worldwide for the treatment of moderate to severe Alzheimer's disease. The company is headquartered in Frankfurt am Main, Germany. To learn more about Merz, visit http://www.merz.com.


News Articles [1565 Associated News Articles listed on BioPortfolio]

Merz Pharma GmbH Co. KGaA Mergers Acquisitions MA, Partnerships Alliances and Investment Report [Updated: 02052017] Prices from USD $350

Merz Pharma GmbH Co. KGaA Mergers Acquisitions MA, Partnerships Alliances and Investment ReportSummaryMarketline's Merz Pharma GmbH Co. KGaA Mergers Acquisitions MA, Partnerships Alliances and ...

Merz Pharma GmbH Co. KGaA Mergers Acquisitions MA, Partnerships Alliances and Investment Report [Report Updated: 12062017] Prices from USD $350

Merz Pharma GmbH Co. KGaA Mergers Acquisitions MA, Partnerships Alliances and Investment ReportSummaryMarketline's Merz Pharma GmbH Co. KGaA Mergers Acquisitions MA, Partnerships Alliances and ...

Merz nabs Allergan exec to head US neurosciences business

Merz Neuroscience, a division of Merz North America, today announced that Kevin O’Brien will join the…

Allergan Veteran Kevin O’Brien Moves to Merz to Lead Neurosciences

Kevin O’Brien, a 16-year veteran of Allergan (NYSE: AGN), is joining Merz North America as vice president and U.S. head of neurosciences. O’Brien had held various roles in Allergan’s dermatology...

Merz Pharma Group Withdraws Proposal to Acquire Obagi Medical Products

FRANKFURT, Germany, April 8, 2013 /PRNewswire/ -- Merz Pharma Group ("Merz" or "the Company") today announced that it has withdrawn its non-binding proposal to acquire all of the outstanding comm...

Merz Neurosciences Announces Positive Phase III Results of Xeomin® (IncobotulinumtoxinA) for Sialorrhea at 2017 MDS Meeting

Wednesday, June 7th 2017 at 6:00pm UTC RALEIGH, N.C.–(BUSINESS WIRE)– Merz Neurosciences, a division of Merz North America, announced today positive topline results from its pivotal Phase ...

Merz Announces Kevin O’Brien as Vice President and U.S. Head of Neuroscience Business

Merz Neuroscience, a division of Merz North America, today announced that Kevin O’Brien will join as the Vice President and U.S. Head of Neurosciences, effective immediately. Mr...

MerLion Pharmaceuticals GmbH And Awarded DTRA Grant To Explore The Use Of Finafloxacin Against Biological Threat Agents

  Life Sciences Jobs   ...

PubMed Articles [174 Associated PubMed Articles listed on BioPortfolio]

Safety and efficacy of incobotulinumtoxinA doses up to 800 U in limb spasticity: The TOWER study.

To evaluate safety (primary objective) and efficacy of increasing doses (400 U up to 800 U) of incobotulinumtoxinA (Xeomin, Merz Pharmaceuticals GmbH) for patients with limb spasticity.

DIC in Decompensated Cirrhosis caused by Prothrombin Complex Concentrate and Recombinant Activated Factor VII: A Word of Caution.

We would like to respond to Scott et al. and the accompanying editorial.(1,2) Concentrated factor products like recombinant activated factor VII (NovoSeven(®) , Novo Nordisk Pharmaceuticals Inc.) an...

Announcing the 2017 Pharmaceuticals Travel Award for Young Post-Doctoral Researchers.

Last year, for the first time in its history, our Journal was able to offer a travel grant of 800 CHF to a young researcher in the field of medicinal chemistry.

Suspended solids moderate the degradation and sorption of waste water-derived pharmaceuticals in estuarine waters.

This study focuses on the fate of pharmaceuticals discharged into an estuarine environment, particularly into the Turbidity Maximum Zone (TMZ). Batch experiments were set up to investigate the factors...

Chiral pharmaceuticals: A review on their environmental occurrence and fate processes.

More than 50% of pharmaceuticals in current use are chiral compounds. Enantiomers of the same pharmaceutical have identical physicochemical properties, but may exhibit differences in pharmacokinetics,...

Clinical Trials [234 Associated Clinical Trials listed on BioPortfolio]

Evaluation of the Sensitivity of Merz Lips Fullness Assessment Scale Following Etermis 4® Treatment for Lips Volume Augmentation

Primary objective: - To evaluate the sensitivity of the Merz Lip Fullness Assessment Scale (MLFAS). Secondary objectives: - To evaluate the clinical aesthetic improvement outco...

Fasting Bioequivalence Study of Memantinol 20 mg Tablets Versus Akatinol Memantine® 20 mg Tablets In Normal Healthy Subjects

This study are two-way crossover, open-label, single-dose, fasting, bioequivalence study of Memantinol® (JSC "GEROPHARM", Russia) 20 mg tablets versus Akatinol Memantine® (Merz Pharma Gm...

Bioequivalence Study of Linagliptin From Prevaglip 5 mg Tablets(Eva Pharma, Egypt) and Trajenta 5 mg Tablets (Boehringer Ingelheim International GmbH, Germany)

An open label randomized, single dose, two-way crossover bioequivalence study to determine the bioequivalence of Linagliptin from Prevaglip 5 mg tablets(Eva pharma for Pharmaceuticals & Me...

The Influence of Glutamate on Memory in Humans

The hippocampus is particularly laden with n-methyl-d-aspartate (NMDA) receptors, and is at the same time one of the most important sites in declarative memory. The rationale of this study...

Bioequivalence Study Comparing Two Test Products With One Reference Product, All Containing 5 mg Yohimbine

- Type: Bioequivalence study in male healthy volunteers, therapeutical indication (erectile disfunction) not studied - Products, dosage, and route of administration: ...

Companies [1803 Associated Companies listed on BioPortfolio]

Merz Pharmaceuticals GmbH and DiaGenic ASA

Merz Pharmaceuticals researches, develops, produces and distributes innovative pharmaceutical products in the areas of neurology and psychiatry as well as in aesthetic dermatology and metabolism. ...

Merz Pharmaceuticals

Merz Pharmaceuticals, LLC is a part of Merz, Inc., a wholly owned U.S. subsidiary of the Merz Group of Companies and was established in 1995 to develop and commercialize products for the Merz Group. ...

DiaGenic ASA & Ferrer inCode

DiaGenic is an innovative Norwegian biotechnology company that seeks to create value for patients, partners, and investors by developing new and more patient friendly methods for ...

Merz Pharma Canada Ltd.

Merz Pharma Canada Ltd. a wholly owned subsidiary of the Merz Group of Companies was established in 2009 to expand Merz franchises in the Canadian Marketplace.

Merz Pharmaceuticals, LLC

Friedrich Merz began his company in 1908 with his first invention—a patented, water-soluble base for topical therapy. Through a series of additional inventions and subsequent acquisitions, he p...

More Information about "Merz Pharmaceuticals GmbH and DiaGenic ASA" on BioPortfolio

We have published hundreds of Merz Pharmaceuticals GmbH and DiaGenic ASA news stories on BioPortfolio along with dozens of Merz Pharmaceuticals GmbH and DiaGenic ASA Clinical Trials and PubMed Articles about Merz Pharmaceuticals GmbH and DiaGenic ASA for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Merz Pharmaceuticals GmbH and DiaGenic ASA Companies in our database. You can also find out about relevant Merz Pharmaceuticals GmbH and DiaGenic ASA Drugs and Medications on this site too.

Quick Search
Advertisement
 

Relevant Topics

Neurology - Central Nervous System (CNS)
Alzheimer's Disease Anesthesia Anxiety Disorders Autism Bipolar Disorders Dementia Epilepsy Multiple Sclerosis (MS) Neurology Pain Parkinson's Disease Sleep Disorders Neurology is the branch of me...

Psychiatry
Psychiatry is the study of mental disorders and their diagnosis, management and prevention.  Conditions include schizophrenia, severe depression and panic disorders among others. There are pharmaceutical treatments as well as other therapies to help...


Corporate Database Quicklinks



Searches Linking to this Company Record